12 Août Review of winter testing requirements
Welcome back to the latest blog! As we edge closer to the winter season. This year will be a pivotal time for testing compared to previous years. Each year during the...
Welcome back to the latest blog! As we edge closer to the winter season. This year will be a pivotal time for testing compared to previous years. Each year during the...
Novacyt’s Near-Patient Test System (NPTS) for COVID-19 Introduction The value of testing for COVID-19 is well documented not only in the UK, but globally as we reflect on how the disease has...
De nouvelles opportunités majeures de croissance Paris, France et Camberley, Royaume-Uni – 27 juillet 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, fait un...
Hello! Welcome back to our latest blog. All departments have been working tirelessly to find an innovative solution following the bottle-neck of scarce raw materials that clinicians require to test. SARS-CoV-2 is...
Paris, France et Camberley, Royaume-Uni – 22 juillet 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce le lancement d'un essai clinique par...
Croissance de 900% du chiffre d’affaires Remboursement de la dette et fort flux de trésorerie positifPoursuite de la demande de tests du COVID-19 attendue en 2021 Paris, France et Camberley, Royaume-Uni...
Paris, France et Camberley, Royaume-Uni – 30 juin 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce que le rapport annuel et les...
Paris, France et Camberley, Royaume-Uni – 18 juin 2020 –Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce le lancement de trois nouveaux produits destinés à aider les...
Welcome to our latest blog! There have been many changes since our last blog, worldwide and within the company, our strong commitment to support testing remains. Since our last update, we...